Abstract:This study explores a previously overlooked nCas9‐centric strategy for enhancement of base editors (BE). Structure‐guided protein engineering establishes nCas9 variants that can commonly enhance a collection of BE tools. In support of their translational potential, the engineered CBE and ABE variants respectively enable 82% and 25% higher rates of editing than the controls in primary human T‐cells. Base editors (BEs) are a recent generation of genome editing tools that couple a cytidine or adenosine deaminase activity to a catalytically impaired Cas9 moiety (nCas9) to enable specific base conversions at the targeted genomic loci. Given their strong application potential, BEs are under active developments toward greater levels of efficiency and safety. Here, a previously overlooked nCas9‐centric strategy is explored for enhancement of BE. Based on a cytosine BE (CBE), 20 point mutations associated with nCas9‐target interaction are tested. Subsequently, from the initial positive X‐to‐arginine hits, combinatorial modifications are applied to establish further enhanced CBE variants (1.1–1.3). Parallel nCas9 modifications in other versions of CBEs including A3A‐Y130F‐BE4max, YEE‐BE4max, CGBE, and split‐AncBE4max, as well as in the context of two adenine BEs (ABE), likewise enhance their respective activities. The same strategy also substantially improves the efficiencies of high‐fidelity nCas9/BEs. Further evidence confirms that the stabilization of nCas9‐substrate interactions underlies the enhanced BE activities. In support of their translational potential, the engineered CBE and ABE variants respectively enable 82% and 25% higher rates of editing than the controls in primary human T‐cells. This study thus demonstrates a highly adaptable strategy for enhancing BE, and for optimizing other forms of Cas9‐derived tools.

Docking Sites Inside Cas9 For Adenine Base Editing Diversification And Rna Off-Target Elimination

Engineering domain-inlaid SaCas9 adenine base editors with reduced RNA off-targets and increased on-target DNA editing

Cas9-orthologue-mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences

Engineering precise adenine base editor with infinitesimal rates of bystander mutations and off-target editing

TadA orthologs enable both cytosine and adenine editing of base editors

Engineering a Precise Adenine Base Editor with Minimal Bystander Editing.

Domain-inlaid Nme2Cas9 adenine base editors with improved activity and targeting scope

Engineered domain-inlaid Nme2Cas9 adenine base editors with increased on-target DNA editing and targeting scope

Engineering Nme2Cas9 Adenine Base Editors with Improved Activity and Targeting Scope

Rational Design of Enhanced Nme2Cas9 and Nme2 Cas9 Nucleases and Base Editors

Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo

Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing

nCas9 Engineering for Improved Target Interaction Presents an Effective Strategy to Enhance Base Editing

Fine-Tuning Cas9 Activity with a Cognate Inhibitor AcrIIA4 to Improve Genome Editing in <i>Streptomyces</i>

Multiplexed base editing through Cas12a variant-mediated cytosine and adenine base editors

Decreasing predictable DNA off-target effects and narrowing editing windows of adenine base editors by fusing human Rad18 protein variant

TadA reprogramming to generate potent miniature base editors with high precision

Cooperativity between Cas9 and hyperactive AID establishes broad and diversifying mutational footprints in base editors

Expanding C–T base editing toolkit with diversified cytidine deaminases

Cas9 variants expand the targeting scope of base editing systems in bacteria

ACBE, a new base editor for simultaneous C-to-T and A-to-G substitutions in mammalian systems